From: Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
Plasma Aβ levels (per SD increase) | Incident dementia (n = 79) HR (95% CI)a | |
---|---|---|
APOE-ε4 carriers (n = 35) | APOE-ε4 non-carriers (n = 44) | |
Aβ1–38 | 1.58 (1.01–2.89) b | 1.10 (0.66–1.83) |
Aβ1–40 | 1.03 (0.58–1.83) | 1.04 (0.64–1.71) |
Aβ1–42 | 1.07 (0.76–1.52) | 1.47 (1.09–1.99) b |
Aβ1–40/Aβ1–42 ratio | 0.72 (0.41–1.26) | 0.75 (0.45–1.16) |